Health regulator authorizes Phase 3 clinical trials in Brazil of new Covid-19 vaccine,

The vaccine is jointly developed by Canadian company Medicago and British pharma giant GSK. Phase 3 clinical trials will be conducted in Brazil …, The vaccine is jointly developed by Canadian company Medicago and British pharma giant GSK. Phase 3 clinical trials will be conducted in Brazil …, Read More

Scroll to Top